Contraceptive prevalence, any modern method in Korea
Korea: Contraceptive prevalence, any modern method was 67.6% in 2021. ◆ Volatile
Contraceptive prevalence, any modern method in Korea, 1965–2021
Source: Household surveys, United Nations (UN), note: Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division. Measured in % of married women ages 15-49.
Analysis
The most recent figure for contraceptive prevalence, any modern method in Korea is 67.6%, measured in 2021.
Over the whole period, contraceptive prevalence, any modern method in Korea peaked at 69.5% in 1991 and was at its lowest, 14.0%, in 1965.
That places Korea 15th out of 113 countries with data for 2021, putting it in the top quarter.
Contraceptive prevalence, any modern method in Korea, year by year
| Year | % of married women ages 15-49 | Change |
|---|---|---|
| 1965 | 14.0% | — |
| 1966 | 15.0% | +7.1% |
| 1971 | 20.1% | +33.8% |
| 1974 | 27.0% | +34.5% |
| 1979 | 43.1% | +59.6% |
| 1982 | 47.4% | +10.0% |
| 1991 | 69.5% | +46.6% |
| 2021 | 67.6% | -2.7% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1960s | 14.5% | 14.0% | 15.0% | 2 |
| 1970s | 30.1% | 20.1% | 43.1% | 3 |
| 1980s | 47.4% | 47.4% | 47.4% | 1 |
| 1990s | 69.5% | 69.5% | 69.5% | 1 |
| 2020s | 67.6% | 67.6% | 67.6% | 1 |
Countries ranked near Korea
- 12 Costa Rica 70.0% compare
- 13 Mexico 69.1% compare
- 14 Korea, Democratic People's Republic of 68.8% compare
- 16 Honduras 66.5% compare
- 17 Paraguay 66.4% compare
- 18 United States of America 66.1% compare
More health data for Korea
- Un projection of annual infant deaths, annual growth rate -1.43 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.1935 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 2,072 deaths per 1,000 people (2090)
- Number of infants who die before age 1 69 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -2.66 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0118 units per person (2025)
- Population ages 00-04, male, annual growth rate -2.76 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is contraceptive prevalence, any modern method in Korea?
- Contraceptive prevalence, any modern method in Korea was 67.6% in 2021, according to Household surveys, United Nations (UN), note: Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division.
- What is the highest contraceptive prevalence, any modern method recorded in Korea?
- The highest recorded value was 69.5% in 1991.
- What is the lowest contraceptive prevalence, any modern method recorded in Korea?
- The lowest recorded value was 14.0% in 1965.
- How does Korea rank for contraceptive prevalence, any modern method?
- Korea ranks 15th out of 113 countries with data for 2021.
- Where does this Korea data come from?
- The figures come from Household surveys, United Nations (UN), note: Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division, published as part of Contraceptive prevalence, any modern method (% of married women ages 15-49). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 8 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Contraceptive prevalence, any modern method is the percentage of married women ages 15-49 who are practicing, or whose sexual partners are practicing, at least one modern method of contraception. Modern methods of contraception include female and male sterilization, oral hormonal pills, the intra-uterine device (IUD), the male condom, injectables, the implant (including Norplant), vaginal barrier methods, the female condom and emergency contraception.